title: The Molecular Chaperone GRP78/BiP in the Development of Chemoresistance: Mechanism and Possible Treatment.
abstract: Treatment of several types of cancer such as lung, breast, prostate, and pancreas has shown notable progresses in the past decades. However, after an initial response, tumors eventually became resistant to chemotherapy. This phenomenon, known as chemoresistance, accounts for the death of most cancer patients. Several studies in patients refractory to therapy have revealed the upregulation of the molecular chaperone GRP78/Binding Protein, BiP (BiP) both at the RNA and protein expression level. Furthermore GRP78/BiP relocates to the cell membrane in malignant but not in benign cells. In this communication we review studies on the role and the mechanism of action of GRP78/BiP during development of chemoresistance in cancer cells. In addition we discuss the possible role of GRP78 as a biomarker and as a target in cancer therapy.
authors: Institute of Toxicology and Genetics, Karlsruhe Institute of Technology Eggenstein-Leopoldshafen, Germany.
authors: Corinna
authors: C
authors: Roller
authors: Danilo
authors: D
authors: Maddalo
keywords: cell stress; chaperone; drug resistance; therapy; unfolded protein response
references: PLoS One. 2012;7(10):e45690
references: 23049684
references: Br J Haematol. 2011 Jun;153(6):741-52
references: 21517817
references: J Biol Chem. 2004 Oct 29;279(44):45495-502
references: 15322075
references: Hum Pathol. 2007 Oct;38(10):1547-52
references: 17640713
references: Mt Sinai J Med. 2004 Oct;71(5):289-97
references: 15543429
references: Clin Cancer Res. 1997 Dec;3(12 Pt 1):2405-14
references: 9815641
references: Cancer Res. 2006 Sep 15;66(18):9260-9
references: 16982771
references: Cancer Res. 2010 Jun 1;70(11):4550-9
references: 20484031
references: Genomics. 1994 Mar 15;20(2):281-4
references: 8020977
references: Nature. 1983 Nov 24-30;306(5941):387-9
references: 6417546
references: Breast Cancer Res Treat. 2000 Jan;59(1):15-26
references: 10752676
references: Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):5987-93
references: 17062670
references: Cancer Res. 2006 Aug 15;66(16):8182-91
references: 16912197
references: PLoS One. 2009 Aug 31;4(8):e6868
references: 19718440
references: Cell. 2007 Jun 29;129(7):1337-49
references: 17604722
references: Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19444-9
references: 19033462
references: Cell. 1993 Jun 18;73(6):1197-206
references: 8513503
references: Cancer Biol Ther. 2010 Jan;9(2):142-52
references: 20368692
references: Melanoma Res. 2012 Jun;22(3):225-35
references: 22495669
references: Mol Cell Biol. 2002 Nov;22(21):7405-16
references: 12370288
references: Breast Cancer Res Treat. 1999 Mar;54(2):135-46
references: 10424404
references: Cell. 2001 Dec 28;107(7):881-91
references: 11779464
references: Mol Cancer Res. 2008 Aug;6(8):1268-75
references: 18708359
references: Nat Rev Cancer. 2004 Dec;4(12):966-77
references: 15573118
references: Int J Cancer. 2010 Dec 1;127(11):2685-98
references: 20178102
references: Int J Cancer. 2011 Feb 1;128(3):726-31
references: 20473863
references: Cancer Res. 2005 Jul 1;65(13):5785-91
references: 15994954
references: J Pathol. 2011 Jan;223(1):81-7
references: 21125667
references: Biochem J. 1999 Apr 1;339 ( Pt 1):135-41
references: 10085237
references: Mol Ther. 2005 Jan;11(1):149-59
references: 15585416
references: Nature. 2006 Oct 5;443(7111):548-52
references: 17024087
references: Mol Cancer Ther. 2007 Jan;6(1):326-33
references: 17237291
references: Cancer Cell. 2004 Sep;6(3):275-84
references: 15380518
references: Lab Invest. 2008 Apr;88(4):375-86
references: 18268478
references: Antioxid Redox Signal. 2009 Sep;11(9):2307-16
references: 19309259
references: Mol Cell Biol. 2001 Feb;21(4):1249-59
references: 11158311
references: Bioorg Med Chem Lett. 2008 Mar 1;18(5):1632-6
references: 18243696
references: J Biol Chem. 2000 Sep 1;275(35):27013-20
references: 10856300
references: J Antibiot (Tokyo). 2005 Mar;58(3):206-9
references: 15895530
references: Br J Cancer. 2009 Nov 17;101(10):1692-8
references: 19861963
references: Cancer Res. 2007 Oct 15;67(20):9809-16
references: 17942911
references: Mol Cell. 2001 Jun;7(6):1165-76
references: 11430820
references: Cancer Sci. 2009 Feb;100(2):327-33
references: 19068091
references: Cancer Res. 2006 Aug 15;66(16):7849-53
references: 16912156